Clinical trial Recruiting at 3 sites Observational Ages 18 and up

Evaluating the safety and performance of SpineVision's posterior fixation systems for spinal treatment

Official title: Safety and Performance of the SpineVision Posterior Fixation Systems Lumis®, Plus® and Ulis® in Thoracolumbar Spinal Degenerative Pathologies or Degenerative Disc Disease (DDD) Associated Pathologies Treatment - Fixed D3 Study

Run by Spinevision Sas · NCT06342765 · Data updated 2026-11-12

This study is testing how safe and effective three different SpineVision devices are for treating people with spinal problems in their lower back.

More Intervertebral Disc Degeneration trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment330 (estimated)
SponsorSpinevision Sas
Industry-sponsored
Locations3 sites (Bayonne and 2 other locations)
StatusRecruiting
StartedSeptember 22, 2022
Main results expectedMay 30, 2028
Study endsMay 30, 2028
Registry record updatedMarch 18, 2026
Trial IDNCT06342765 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older who have been implanted with the Lumis®, Plus®, or Ulis® posterior fixation systems.

Probably not a fit

Patients with contraindications such as trauma, known allergies to the implant materials, or other serious medical conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the safety and effectiveness of three SpineVision posterior fixation systems—Lumis®, Plus®, and Ulis®—in treating patients with thoracolumbar spinal degenerative conditions. Participants, either already implanted with these systems or scheduled for surgery, will be monitored for up to 24 months post-implantation. Data collected will include pain levels, disability scores, and any adverse events experienced. The study employs a multicentric, non-randomized design to gather comprehensive insights into patient outcomes.

Why it matters

Potential benefit: If successful, this study could enhance treatment protocols for patients suffering from intervertebral disc degeneration by confirming the safety and effectiveness of these fixation systems.

How similar studies have gone: While this study builds on existing knowledge of spinal fixation systems, its specific focus on the SpineVision systems in a multicentric observational context is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient implanted with Lumis®, Plus® or Ulis® posterior fixation system
* Patient of 18 years old and more
* Patient has provided signed informed consent or did not oppose to his/her data collection, per local regulation

Exclusion Criteria: contra-indication

* trauma (i.e., fracture or dislocation)
* Known or suspected allergy or intolerance to the implanted material, mainly to metal (e.g., cobalt, chromium, nickel, etc.)
* Any other medical or surgical condition likely to compromise the success of instrumented surgery, such as the presence of a malignant tumor or serious congenital abnormalities, raised erythrocyte sedimentation rate not explained by other diseases, high white blood cell count or a tendency to low white blood cell count
* All cases not described in the indications
* Localized infection of the operative site
* All patients with insufficient tissue cover of the operative site
* Local signs of inflammation
* Fever or leukocytosis
* Pathological obesity
* Pregnancy
* Mental illness
* Rapidly evolving joint diseases, bone absorption, osteopenia and/or osteoporosis. Osteoporosis is a relative contraindication, as this medical condition can limit the expected correction gain and stability of mechanical fixation
* All cases not requiring bone graft or bone fusion
* When pedicular screws are used, absence or malformation of pedicles
* All cases requiring a combination of different metals
* All patients not agreeing to comply with post-operative instructions

Where it's running

  • DOSCEA Pôle Rachis
    Bayonne, France
    Recruiting
  • Clinique du dos Bordeaux-Terrefort
    Bruges, France
    Recruiting
  • Orthéo Neurochirurgie
    Saint-Etienne, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.